1. Manna P, Das J, Ghosh J, Sil PC. Contribution of type 1 diabetes to rat liver dysfunction and cellular damage via activation of NOS, PARP, IkappaBalpha/NF-kappaB, MAPKs, and mitochondria-dependent pathways: Prophylactic role of arjunolic acid. Free Radic Biol Med 2010; 48:1465-1484.
2. Pirart J. Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973. Diabetes Care 1978; 1:168-188.
3. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27:1047-1053.
4. Klein R KB, Moss SE. Visual impairment in diabetes. Ophthalmology 1984; 91:1–9.
5. Yau JW, Rogers S, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 2012; 35:556-564.
6. Chew EY, Ferris FL, Csaky KG, Murphy RP, Agrón E, Thompson DJS, et al. The long-term effects of laser photocoagulation treatment in patients with diabetic retinopathy. Ophthalmology 2003; 110:1683-1689.
7. Early Treatment Diabetic Retinopathy Study Research Group. Early Photocoagulation for Diabetic Retinopathy. Ophthalmology 1991; 98:766-785.
8. Chang YH, Chen PL, Tai MC, Chen CH, Lu DW, Chen JT. Hyperbaric oxygen therapy ameliorates the blood–retinal. Clin Exp Ophthalmol 2006; 24:584-589.
9. Yue S, Dong Y. Drug treatment of diabetic retinopathy. China Med Herald 2007; 32:005.
10. Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet 2010; 376:124–136.
11. Joussen AM, Poulaki V, Le ML, Koizumi K, Esser C, Janicki H, et al. A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J 2004; 18:1450-1452.
12. Frey T, Antonetti DA. Alterations to the blood-retinal barrier in diabetes: cytokines and reactive oxygen species. Antioxid Redox Signal 2011; 15:1271-1284.
13. Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res 2010; 107:1058-1070.
14. Mahmoud AM, Ashour MB, Abdel-Moneim A, Ahmed OM. Hesperidin and naringin attenuate hyperglycemia-mediated oxidative stress and proinflammatory cytokine production in high fat fed/streptozotocin-induced type 2 diabetic rats. J Diabetes Complications 2012; 26:483-490.
15. Mahoney SE, Loprinzi PD. Influence of flavonoid-rich fruit and vegetable intake on diabetic retinopathy and diabetes-related biomarkers. J Diabetes Complications 2014; 28:767-771.
16. Falcone Ferreyra ML, Emiliani J, Rodriguez EJ, Campos-Bermudez VA, Grotewold E, Casati P. The identification of maize and Arabidopsis type I flavone synthases links flavones with hormones and biotic interactions. Plant Physiol 2015; 169:1090-1107.
17. Schijlen EG, Ric de Vos CH, van Tunen AJ, Bovy AG. Modification of flavonoid biosynthesis in crop plants. Phytochemistry 2004; 65:2631-2648.
18. Igual M, Garcia-Martinez E, Camacho MM, Martinez-Navarrete N. Jam processing and storage effects on β-carotene and flavonoids content in grapefruit. J Funct Foods 2013; 5:736-744.
19. Banjerdpongchai R, Wudtiwai B, Khaw-On P, Rachakhom W, Duangnil N, Kongtawelert P. Hesperidin from Citrus seed induces human hepatocellular carcinoma HepG2 cell apoptosis via both mitochondrial and death receptor pathways. Tumour Biol 2016; 37:227-237.
20. Castillo J, Benavente-Garcia O, Del Rio JA. Study and optimization of citrus flavanone and flavones elucidation by reverse phase HPLC with several mobile phases: influence of the structural characteristics. J Liq Chromatogr Relat Technol 1994; 17:1497-1523.
21. Pierre M, Emile MG, Jacques E. Column liquid chromatographic determination of flavanone glycosides in Citrus_ Application to grapefruit and sour orange juice adulterations. J Chromatogr 1993; 634:129-134.
22. Ali MM, El Kader MA. The influence of naringin on the oxidative state of rats with streptozotocin-induced acute hyperglycaemia. Z Naturforsch C 2004; 59:726-733.
23. Lambev I, Krushkov I, Zheliazkov D, Nikolov N. Antiexudative effect of naringin in experimental pulmonary edema and peritonitis. Eksp Med Morfol 1979; 19:207-212.
24. Martin MJ, Marhuenda E, Perez-Guerrero C, Franco JM. Antiulcer effect of naringin on gastric lesions induced by ethanol in rats. Pharmacology 1994; 49:144-150.
25. So FV, Guthrie N, Chambers AF, Moussa M, Carroll KK. Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices. Nutr Cancer 1996; 26:167-181.
26. Ratana B, Benjawan W, Patompong K. Induction of human hepatocellular carcinoma HepG2 cell apoptosis by naringin. Asian Pac J Cancer P 2016; 17:3289-3294.
27. Kandhare AD, Ghosh P, Bodhankar SL. Naringin, a flavanone glycoside, promotes angiogenesis and inhibits endothelial apoptosis through modulation of inflammatory and growth factor expression in diabetic foot ulcer in rats. Chem Biol Interact 2014; 219:101-112.
28. Kandhare AD, Raygude KS, Ghosh P, Ghule AE, Bodhankar SL. Neuroprotective effect of naringin by modulation of endogenous biomarkers in streptozotocin induced painful diabetic neuropathy. Fitoterapia 2012; 83:650-659.
29. Chen F, Zhang N, Ma X, Huang T, Shao Y, Wu C, et al. Naringin alleviates diabetic kidney disease through inhibiting oxidative stress and inflammatory reaction. PLoS One 2015; 10:e0143868.
30. Barber AJ. A new view of diabetic retinopathy: a neurodegenerative disease of the eye. Prog Neuropsycho-pharmacol Biol Psychiatry 2003; 27:283-290.
31. Lieth E, Barber AJ, Xu B, Dice C, Ratz MJ, Tanase D, et al. Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Penn State Retina Research Group. Diabetes 1998; 47:815-820.
32. van Dijk HW, Verbraak FD, Kok PH, Garvin MK, Sonka M, Lee K, et al. Decreased retinal ganglion cell layer thickness in patients with type 1 diabetes. Invest Ophthalmol Vis Sci 2010; 51:3660-3665.
33. Kowluru RA, Chan PS. Oxidative stress and diabetic retinopathy. Exp Diabetes Res 2007; 2007:43603.
34. Kumar B, Gupta SK, Srinivasan BP, Nag TC, Srivastava S, Saxena R, et al. Hesperetin rescues retinal oxidative stress, neuroinflammation and apoptosis in diabetic rats. Microvasc Res 2013; 87:65-74.
35. Bucolo C, Leggio GM, Drago F, Salomone S. Eriodictyol prevents early retinal and plasma abnormalities in streptozotocin-induced diabetic rats. Biochem Pharmacol 2012; 84:88-92.
36. Tang J, Kern TS. Inflammation in diabetic retinopathy. Prog Retin Eye Res 2011; 30:343-358.
37. Rahimi R, Nikfar S, Larijani B, Abdollahi M. A review on the role of antioxidants in the management of diabetes and its complications. Biomed Pharmacother 2005; 59:365-373.
38. Li N, Karin, M. Is NF-κB the sensor of oxidative stress? FASEB J 1999; 13:1137-1143.
39. Liu Y, Wu H, Nie YC, Chen JL, Su WW, Li PB. Naringin attenuates acute lung injury in LPS-treated mice by inhibiting NF-kappaB pathway. Int Immunopharmacol 2011; 11:1606-1612.
40. Chtourou Y, Aouey B, Kebieche M, Fetoui H. Protective role of naringin against cisplatin induced oxidative stress, inflammatory response and apoptosis in rat striatum via suppressing ROS-mediated NF-kappaB and P53 signaling pathways. Chem Biol Interact 2015; 239:76-86.
41. Sharma AK, Bharti S, Ojha S, Bhatia J, Kumar N, Ray R, et al. Up-regulation of PPARgamma, heat shock protein-27 and -72 by naringin attenuates insulin resistance, beta-cell dysfunction, hepatic steatosis and kidney damage in a rat model of type 2 diabetes. Br J Nutr 2011; 106:1713-1723.